BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18781129)

  • 21. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
    Thallinger C; Werzowa J; Poeppl W; Kovar FM; Pratscher B; Valent P; Quehenberger P; Joukhadar C
    J Invest Dermatol; 2007 Oct; 127(10):2411-7. PubMed ID: 17508024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy of murine colorectal carcinoma with cisplatin and cisplatin plus 3'-deoxy-3'-azidothymidine.
    Klann RC; Holbrook CT; Nyce JW
    Anticancer Res; 1992; 12(3):781-7. PubMed ID: 1535769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin.
    Oda A; Katayose Y; Yabuuchi S; Yamamoto K; Mizuma M; Shirasou S; Onogawa T; Ohtsuka H; Yoshida H; Hayashi H; Rikiyama T; Kim H; Choe Y; Kim K; Son H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2009 Apr; 29(4):1201-9. PubMed ID: 19414365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of chemotherapy with cisplatin and rapamycin against Hep-2 cells in vitro].
    Lei WB; Jia T; Su ZZ; Wen WP; Zhu XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1838-41. PubMed ID: 18971185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
    Singh V; Singh SM
    Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeutics.
    Sk UH; Prakasha Gowda AS; Crampsie MA; Yun JK; Spratt TE; Amin S; Sharma AK
    Eur J Med Chem; 2011 Aug; 46(8):3331-8. PubMed ID: 21609852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest.
    Jiang W; Mikochik PJ; Ra JH; Lei H; Flaherty KT; Winkler JD; Spitz FR
    Cancer Res; 2007 Feb; 67(3):1221-7. PubMed ID: 17283158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.
    Pantazis P; Early JA; Mendoza JT; DeJesus AR; Giovanella BC
    Cancer Res; 1994 Feb; 54(3):771-6. PubMed ID: 8306340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and identification of small molecules that potently induce apoptosis in melanoma cells through G1 cell cycle arrest.
    Dothager RS; Putt KS; Allen BJ; Leslie BJ; Nesterenko V; Hergenrother PJ
    J Am Chem Soc; 2005 Jun; 127(24):8686-96. PubMed ID: 15954774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis.
    Jansen B; Schlagbauer-Wadl H; Eichler HG; Wolff K; van Elsas A; Schrier PI; Pehamberger H
    Cancer Res; 1997 Feb; 57(3):362-5. PubMed ID: 9012455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
    McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
    Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-beta therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells.
    Kubo H; Ashida A; Matsumoto K; Kageshita T; Yamamoto A; Saida T
    Arch Dermatol Res; 2008 Jul; 300(6):297-301. PubMed ID: 18324409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of fusarochromanone on melanoma growth.
    Dréau D; Foster M; Hogg M; Culberson C; Nunes P; Wuthier RE
    Anticancer Drugs; 2007 Sep; 18(8):897-904. PubMed ID: 17667595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis induction by 4-nerolidylcatechol in melanoma cell lines.
    Brohem CA; Sawada TC; Massaro RR; Almeida RL; Rivelli DP; Ropke CD; da Silva VV; de Lima TM; Curi R; Barros SB; Maria-Engler SS
    Toxicol In Vitro; 2009 Feb; 23(1):111-9. PubMed ID: 19059332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polysaccharides isolated from Phellinus gilvus inhibit melanoma growth in mice.
    Bae JS; Jang KH; Yim H; Jin HK
    Cancer Lett; 2005 Jan; 218(1):43-52. PubMed ID: 15639339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of pyridoxal treatment in controlling the growth of melanomas in cell culture and an animal pilot study.
    Maksymowych AB; Robertson NM; Litwack G
    Anticancer Res; 1993; 13(6A):1925-37. PubMed ID: 8297098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.
    Pellizzari Tregno F; Sau A; Pezzola S; Geroni C; Lapenta C; Spada M; Filomeni G; Bonanno E; Federici G; Caccuri AM
    Eur J Cancer; 2009 Sep; 45(14):2606-17. PubMed ID: 19665369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally administered rapamycin, dacarbazine or both for treatment of human melanoma evaluated in severe combined immunodeficiency mice.
    Thallinger C; Skorjanec S; Soleiman A; Tzaneva S; Griss J; Rous W; Poeppl W; Weinlich G; Karimian-Teherani D; Joukhadar C
    Pharmacology; 2008; 82(3):233-8. PubMed ID: 18810248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.
    Paulitschke V; Schicher N; Szekeres T; Jäger W; Elbling L; Riemer AB; Scheiner O; Trimurtulu G; Venkateswarlu S; Mikula M; Swoboda A; Fiebiger E; Gerner C; Pehamberger H; Kunstfeld R
    J Invest Dermatol; 2010 Jun; 130(6):1668-79. PubMed ID: 19956188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azidothymidine is effective against human multiple myeloma: a new use for an old drug?
    Pereira J; Levy D; Ruiz JL; Brocardo GA; Ferreira KA; Costa RO; Queiroz RG; Maria DA; Neto AE; Chamone DA; Bydlowski SP
    Anticancer Agents Med Chem; 2013 Jan; 13(1):186-92. PubMed ID: 22931421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.